Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Pharmacology | 4 |
Suicide | 4 |
Adolescents | 3 |
Behavior Modification | 2 |
Cognitive Restructuring | 2 |
Counseling Effectiveness | 2 |
Depression (Psychology) | 2 |
Drug Therapy | 2 |
Drug Use | 2 |
Outcomes of Treatment | 2 |
Patients | 2 |
More ▼ |
Author
March, John | 2 |
Silva, Susan | 2 |
Vitiello, Benedetto | 2 |
Casat, Charles | 1 |
Emslie, Graham | 1 |
Harris, Hope Elaine | 1 |
Kratochvil, Christopher | 1 |
Maltsberger, John T. | 1 |
Mayes, Taryn | 1 |
McNulty, Steven | 1 |
Myers, Wade C. | 1 |
More ▼ |
Publication Type
Journal Articles | 4 |
Reports - Research | 4 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating

Harris, Hope Elaine; Myers, Wade C. – Suicide and Life-Threatening Behavior, 1997
Assesses the generality and strength of nonclinical youths' (N=569) perceptions of the harmfulness and lethality of acetaminophen in overdose. Findings indicate that adolescents have ready access to acetaminophen and use it in suicide attempts but underestimate its potential for toxicity, lacking knowledge regarding side effects of overdose. (RJM)
Descriptors: Adolescent Attitudes, Adolescents, Drug Use, Pharmacology

Maltsberger, John T. – Suicide and Life-Threatening Behavior, 1997
Presents a case study on a 19-year-old seaman, without previous psychiatric difficulty, who ingested fifty 500 mg tablets of acetaminophen so as to avoid a frightening event. Two medical doctors comment on the case and suggest appropriate reactions to such events. Includes a discussion on terminology involving the word "suicide." (RJM)
Descriptors: Anxiety, Case Studies, Drug Use, Fear
March, John; Silva, Susan; Vitiello, Benedetto – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Funded by the National Institute of Mental Health, the Treatment for Adolescents With Depression Study (TADS) is intended to evaluate the short-term (12 weeks) and longer-term (36 weeks) effectiveness of four treatments for adolescents with DSM-IV major depressive disorder: clinical management with fluoxetine (FLX), cognitive-behavioral therapy…
Descriptors: Patients, Adolescents, Public Health, Quality of Life
Emslie, Graham; Kratochvil, Christopher; Vitiello, Benedetto; Silva, Susan; Mayes, Taryn; McNulty, Steven; Weller, Elizabeth; Waslick, Bruce; Casat, Charles; Walkup, John; Pathak, Sanjeev; Rohde, Paul; Posner, Kelly; March, John – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO). Method: Safety assessments included adverse events (AEs) collected by spontaneous report, as well as systematic…
Descriptors: Safety, Patients, Adolescents, Suicide